Gilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.
LEARN MOREFirst and only canine flu vaccine built on RNA particle technology
LEARN MOREOur proprietary formulation and patented Immuno-Mist-Râ„¢ technology make it possible.
LEARN MORE